SCHEMBL30707385

SCHEMBL30707385

NC(=O)c1ccn(CC2COC2)n1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 5/20 0.37
KDM4C Q9H3R0 1/20 0.33
KMT2A Q03164 2/20 0.33
POLB P06746 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ALDH1A1 P00352 4/20 0.32
ALDH1A2 O94788 2/20 0.32
ALDH1A3 P47895 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
OPRM1 P35372 2/20 0.31
OPRL1 P41146 1/20 0.31
MAPT P10636 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
FAAH O00519 1/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2827007 0.86 POLB (0.37) KDM4CKMT2APOLBTDP1ALDH1A1
SCHEMBL17076660 0.85 OPRM1 (0.42) IRAK4KMT2APOLBTDP1OPRM1
SCHEMBL31460230 0.81 IRAK4 (0.35) IRAK4KDM4CKMT2APOLBTDP1
SCHEMBL27663461 0.77 PIM1 (0.48) IRAK4
SCHEMBL27663462 0.77 PIM1 (0.48) IRAK4
SCHEMBL28761039 0.77 PIM1 (0.48) IRAK4
SCHEMBL27682836 0.75 PARP1 (0.47) IRAK4KMT2AMAPTCYP2D6
SCHEMBL1080225 0.74 TMEM97 (0.45) KDM4CKMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL2662008 0.74 TMEM97 (0.45) KDM4CKMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL30707190 0.73 ACKR3 (0.34) IRAK4POLBSMN1; SMN2OPRM1FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4540255-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2025-04-23 EP disclosed
WO-2025080986-A1 AMIDE COMPOUNDS QUANTX BIOSCIENCES US, INC. (US) 2025-04-17 WO disclosed
WO-2023244615-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2023-12-21 WO disclosed